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Purpose/Objective: For RT based on MRI only, a promising approach is 
to obtain a substitute CT scan from the MR images (a so-called pseudo 
CT, pCT) using a Gaussian mixture regression (GMR) model. The GMR 
model has previously been investigated on 3T MR images using a dual 
ultra-short echo time (dUTE) sequence and was shown to give 
sufficient information for training the GMR model. The dUTE sequence 
provides contrast between bone and tissue using dual echo times but 
at 1 T, chemical shift artifacts at the second echo time may cause 
voxels containing water and fat to behave like bone. The multiecho-
Dixon (mDixon) MR sequence provides contrast between water and fat 
which could potentially remove this problem and provide valuable 
information for the GMR model. In this study, we investigate the 
robustness of the GMR model on predicting pCT scans from dUTE MR 
images of a 1 T scanner and how adding an mDixon sequence affects 
the generated pCT. 
Materials and Methods: Head scans of 2 patients fixated for whole 
brain RT were acquired on a 1 T open MR scanner with flex coils. dUTE 
sequences were obtained at flip angles 10 and 25 degrees, 
respectively. Echo- and repetition times TE1/TE2/TR were 0.09/3.5 
/7.1 ms with a voxel resolution of 1x1x1 mm and a 256 mm FOV. The 
mDixon was acquired with TE1/dTE/TR equal to 6.9/3.5/16 ms, a 
voxel resolution of 1x1x1.5 mm and a 250.5 mm FOV. CT head scans 
were acquired with a voxel resolution of 0.6x0.6x2 mm and a 220 mm 
FOV. The CT was registered to the high angle TE1 UTE using a mutual 
information algorithm and all MR scans were internally registered. All 
scans were resliced to the dUTE resolution and cropped to the 
smallest FOV. The MR images were low- and high-pass filtered 
creating two new images per filtered image. The MR images, their 
filtered counterparts and the CT image were considered as random 
variables and the voxel intensities a sample from their underlying 
distribution. A GMR model was initialized with 20 centers using k-
means clustering and an EM algorithm was used to train the model on 
the data from one of the patients.The model was then applied on the 
other patient to generate the pCT. A model using only the dUTE 
images and one adding the mDixon images were trained.A comparison 
using the real CT to calculate the mean absolute prediction error 
(MAPD) of the pCT in bins of 20 HU was carried out. 
Results: The pCTs of one patient using the extended model is shown 
in the figure. Qualitatively (upper images) and quantitatively (lower 
graph), the results are similar to those previously reported for 3T 
using dUTE only. A reduction in MAPD can be observed in the bone 
region(>500 HU) by adding mDixon to the model. 
Conclusions: The robustness of a GMR model on 1T MR images was 
demonstrated. The model was further expanded with an mDixon 
sequence which reduced the prediction error of predicted CT values 
>500 HU. Although a study based on larger amounts of data should be 
carried out, there is an indication that the mDixon sequence improves 
CT prediction from dUTE MR images. 
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Purpose/Objective: PET/CT aids target volume definition for many 
tumour sites including meningiomas. Recently simultaneous PET/MR 
(mMR) imaging has become available, but applications in radiotherapy 
planning are undefined. We performed a feasibility study using a 
Siemens Biograph 3T mMR for radiotherapy planning in meningiomas 
using 68Ga-DOTATATE as PET tracer (binds to somatostatin receptors) 
and gadolinium (Gd) enhanced MRI. 
Materials and Methods: Two phantoms (bespoke and Lucy) were 
scanned to assess image distortion and accuracy of mMR co-
registration to planning CT. A customised flat acrylic baseboard 
compatible for mMR and CT was designed and manufactured in-house. 
Body surface coils were used in conjunction with the patient’s 
thermoplastic (TP) radiotherapy head shell. A TP bridge was fitted 
over the shell to support the body surface coil. A healthy volunteer 
underwent mMR scan in the TP shell to establish tolerability (60cm 
bore scanner), shell durability(3T MRI) and anatomic clarity.  
4 patients with meningiomas in different regions underwent mMR 
followed by PET/CT for radiotherapy planning.  
mMR imaging protocol: Part 1 without TP shell ( non-contrast T2 & 
diffusion = 35 mins), attenuation correction, immediately followed by 
Part 2 with TP shell (T1 -/+ Gd), DCEMRI, simultaneous PET images = 
15 minutes). 68Ga-DOTA (100MBq median) was injected prior to Part 1 
to allow 40 minutes uptake before PET imaging in Part 2 (approx 
50mins total in scanner). Patients had PET/CT scan approx 20 mins 
after mMR.  
We assessed patient tolerability, software compatibility, biological 
target volume(BTV) on mMR and PET/CT, co-registration and PET SUV 
with and without the shell. 
Results: Phantom work showed that co-registration and image 
distortion resulted in <1mm uncertainties in all regions assessed. The 
shell and baseboard were compatible with mMR, but attenuated PET 
signal 2.5-19% (increasing attenuation from anterior to posterior 
location). However, the shell increased co-registration accuracy (and 
would permit co-registration in the neck) and did not affect BTV 
delineation. Patients tolerated the protocol.  
mMR images were incompatible with current planning software used 
for PET/CT BTV delineation. A complex solution involving a number of 
different software was developed. BTV was largely the same on mMR 
and PET/CT, but distinguishing tumour from the pituitary was clearer 
on mMR. In PET negative regions where standard MRI/ CT was 
suspicious for tumour, more complex MR sequences (e.g. diffusion) 
can be evaluated on the same slice on mMR, which may increase 
certainty about volume definition. 
Conclusions: It is feasible to use mMR with 68Ga-DOTA and Gd contrast 
for radiotherapy planning, although our current software pathway is 
complex and a simpler solution should be developed. Further study is 
required to establish if mMR permits more accurate BTV delineation. 
Use of mMR may reduce the overall numbers of scans as separate MRI 
is not required and there is potential for post-RT PET research. 
Scanning in shell improves co-registration but attenuates PET SUV. 
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Purpose/Objective: High FDG-uptake within a lung tumor is 
hypothesized to be an indicator of treatment resistance. Current 
treatment planning techniques are able to design dose distributions 
according to the FDG intensity within tumors, i.e. dose-painting 
strategies. Since the apparent FDG distribution in the PET image is 
dependent on PET reconstruction parameters, these parameters also 
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influencethe resulting dose distribution. In the present work, we study 
the effect of different reconstruction parameters on dose distribution 
for both dose painting by contours (DPC) and dose painting by 
numbers (DPBN) techniques.  
Materials and Methods: 18FDG-PET/CT was performed for 8 advanced 
stage non-small cell lung cancer patients on a Siemens Biograph 40 
PET/CT-scanner.For each patient, 6 different PET reconstructions 
were applied; ordered subsets expectation maximization (OSEM) with 
21 subsets, using 2 (OSEM2i), 3 (OSEM3i)and 4 (OSEM4i) iterations. In 
addition, the data was reconstructed using theSiemens HD PET 
algorithm that corrects for the varying point spread function(PSF) 
inside the scanner, with 21 subsets, 2 (PSF2i), 3(PSF3i) and 4 
(PSF4i)iterations. Gaussian post filtering was 5 mm for all cases. A 
GTV was generated for each patient, encompassing the primary lung 
tumor including all voxels with an SUV > 2.0 in the standard OSEM2i 
reconstruction.  
For DPC, a boost volume was defined as the 50% of SUVmax for each 
reconstruction[1]. The boost volumes were assigned doses 
corresponding to an increase in mean GTV dose from 60 to 70 Gy. For 
each boost volume the quality factor (QF) [2] of the dose distribution 
was calculated with reference to the standard reconstruction as well 
as differences in boost volumes. For DPBN, a boost dose was 
distributed ranging from 60 to 130 Gy within the GTV assuming a 
linear relationship between FDG voxel intensity and prescribed dose 
distribution [2],using SUVmax as threshold for voxels receiving 
maximum dose. Dose volume histograms (DVH) were extracted for all 
reconstructions, as well as quality factors (QF) compared to the 
standard reconstruction OSEM2i.  
Results: For DPC, the mean boost volume was 32 ± 9 % and 31 ± 9 % of 
the GTV for OSEM2i and PSF2i, respectively. Correspondingly, the 
mean dose to the boost volume was 91 ± 10 Gyand 95 ± 13 Gy for 
OSEM2i and PSF2i. Considering the different reconstructions, the 
largest observed mean difference in boost volume was -11 ± 6 %, 
between OSEM4i and PSF2i. The mean difference in boost volume for 
OSEM2i and PSF2i was -9 ± 6%. The largest mean QF was 2.1 %, for 
PSF2i.  
For DPBN, for all patients except one, DVHs of the different 
reconstructions were approximately similar. The mean dose to the 
GTV was 81 ± 4 Gy and 80 ± 4 Gy for OSEM2i andPSF2i, respectively. 
The mean QF ofPSF2i relative to OSEM2i was 1.8 ± 0.8 %.  
Conclusions: PET reconstruction settings have an effect on PET-boost 
dose distributions, although the effect is small or moderate for most 
patients.  
[1] van Elmpt, W., De Ruysscher,D., van der Salm, A., et al. Radiother 
Oncol 2012; 104: 67-71. 
[2]Vanderstraten B,De Gersem W, Derie C, et al. Radiother Oncol 
2006; 79; 249-258 
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Purpose/Objective: Pareto front navigation, lexicographic ordering 
and other methods have been suggested to organize, guide and 
accelerate the dose optimization process. These methods are 
currently only feasible for the optimization of fluence weight profiles 
because the optimization of deliverable treatment plans adds greatly 
to their complexity. Thus, it is frequently not possible to maintain the 
carefully established balance between various treatment goals in leaf 
segmentation. We address the problem how a Pareto-optimal dose 
distribution can be preserved throughout the entire optimization, and 
replicated by a deliverable leaf sequence for VMAT or dMLC-IMRT, 
computed with the final dose algorithm. 
Materials and Methods: The method comprises 4 elements: 1) during 
the optimization of fluence profiles, a complimentary set of 
smoothing penalties and novel projection operators prevent 
undeliverable fluence distributions.This minimizes the quality loss due 
to leaf sequencing. 2) once the final dose distribution has been 
accepted, a multitude of features of the DVHs of targets and organs 
are captured in facsimile cost functions and their values recorded as 
reference. 3) after sequencing for VMAT or dMLC-IMRT and dose 
computation with the final algorithm, the leaf positions are iteratively 
adjusted in order to reproduce the previously determined facsimile 
cost function values. 4) as a final resort, the case that the Pareto-
optimum dose distribution cannot be replicated is detected 
automatically, and facsimile cost functions are relaxed in the order of 
the user´s preference, starting with the least significant. The user 
preference is recorded in the initial plan selection process. 
The method was implemented in the research version of a commercial 
planning system. Treatment plans were generated for 6 case classes 
comprising a minimum of 5 patients each. 
Results: Across all case classes, in 92% of cases the quality of the 
Pareto-optimum dose could be replicated or exceeded, but only if the 
following prerequisites were given: 1) the associated fluence profiles 
need to be subjected to rigorous smoothness and deliverability 
constraints so that the plan navigation is not performed on illusionary 
dose distributions. By the same token, the expert can also avoid 
making choices that cannot be realistically delivered. 2) the facsimile 
cost functions need to be organ- and target-specific, simple physical 
similarity measures either under-define (if too few are used) or over-
constrain (if too rigorous ones are used) the leaf sequence 
optimization. 3) for the leaf position optimization, the facsimile cost 
functions need to be treated as hard constraints, not as weighted 
objectives, to guarantee precise replication. 
Conclusions: The presented method replicates the quality of Pareto-
optimum dose distributions with deliverable plans, and thereby 
removes the need to consider highly complex delivery constraints 
during manual solution navigation.  
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Purpose/Objective: Aim of this study is to evaluate the performance 
of 5mm Millennium MLC and compare to a 2.5mm High Definition MLC 
for the treatment of Lung lesions using Volumetric Modulated Arc 
Therapy (VMAT) based Stereotactic Body Radiotherapy(SBRT). 
Materials and Methods: 10 Lung patients treated with SBRT at our 
institute were retrospectively planned with 5mm MMLC & 2.5mm 
HDMLC using VMAT technique. The gross tumor volume ranged from 
2.2 cm3 to 151 cm3. All these patients were treated with 5mm MMLC 
and hence 5mm MMLC plans were kept as reference. The reference 
plans were re-optimized and recomputed with identical planning 
parameters for 2.5 mm HDMLC system. Dose computation was 
performed using AcurosXB Advance dose calculation algorithm in 
Eclipse treatment planning system(Version 10) with tissue in-
homogeneity taken into account. Each plan was normalized such that 
95% of the planning target volume (PTV) receives 100% of the 
prescribed dose. Plan evaluation was performed using figures of 
merit for a rapid and objective assessment on the quality of two 
treatment plans for MMLC & HDMLC. For PTV conformity index (CI), 
Heterogeneity index (HI) were used to quantify the quality whereas 
for normal tissues, Gradient index (GI) defined as ratio of 50 % Isodose 
volume to the prescription Isodose volume & D25(25 % Isodose volume) 
were used. Planning objectives were based on RTOG 0915 guidelines. 
Results: Both the MLC meet the RTOG criteria for the CI and HI. As 
shown in the table-1 the CI range was from 1.07 (151 cm3) to 1.38 (2.2 
cm3) with median of 1.14 + 0.10 for HDMLC & 1.07 (151 cm3) - 
1.44(2.2 cm3) with median of 1.15+ 0.12 for MMLC. For normal tissues 
the GI ranges from 3.61 (151 cm3) to 6.14 (2.2 cm3)as compared to 
3.67 (151 cm3) to 7.22(2.2 cm3) for HDMLC & MMLC respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
